Skip to main content
AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
35.47
+1.81 (5.38%)
At close: Nov 5, 2024, 4:00 PM
34.51
-0.96 (-2.71%)
After-hours: Nov 5, 2024, 6:39 PM EST

AtriCure Revenue

AtriCure had revenue of $115.91M in the quarter ending September 30, 2024, with 17.93% growth. This brings the company's revenue in the last twelve months to $447.57M, up 17.56% year-over-year. In the year 2023, AtriCure had annual revenue of $399.25M with 20.84% growth.

Revenue (ttm)
$447.57M
Revenue Growth
+17.56%
P/S Ratio
3.71
Revenue / Employee
$372,978
Employees
1,200
Market Cap
1.73B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023399.25M68.87M20.84%
Dec 31, 2022330.38M56.05M20.43%
Dec 31, 2021274.33M67.80M32.83%
Dec 31, 2020206.53M-24.28M-10.52%
Dec 31, 2019230.81M29.18M14.47%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Myriad Genetics 802.20M
Kiniksa Pharmaceuticals International, 384.10M
Certara 363.55M
Harrow 154.15M
Ocular Therapeutix 61.10M
Celldex Therapeutics 8.30M
NewAmsterdam Pharma Company 7.42M
Syndax Pharmaceuticals 3.50M
Revenue Rankings

ATRC News

More News